Long-term hematological response in a patient with 5q-syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy

被引：1
|
作者：
Niscola, Pasquale [1 ]
Tendas, Andrea [1 ]
Scaramucci, Laura [1 ]
Merola, Roberta [2 ]
Catalano, Gianfranco [1 ]
de Fabritiis, Paolo [1 ]
机构：
[1] S Eugenio Hosp, Hematol Unit, Rome, Italy
[2] Regina Elena Inst Canc Res, Cytogenet Unit, Dept Clin Pathol, Rome, Italy
来源：
BLOOD RESEARCH | 2014年 / 49卷 / 02期
关键词：
D O I：
10.5045/br.2014.49.2.130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：130 / 132
页数：3
相关论文
共 50 条
  • [1] LONG-TERM ERYTHROID RESPONSE IN A PATIENT WITH 5Q-SYNDROME AFTER LENALIDOMIDE DISCONTINUATION
    Freyrie, A.
    Guidotti, F.
    Guarco, S.
    LEUKEMIA RESEARCH, 2015, 39 : S93 - S94
  • [2] Long-Term Maintenance of Hematological and Cytogenetic Remission in 5q-Syndrome After Short-Term Administration of Lenalidomide
    Kawaji, Yuka
    Kaneko, Hiroto
    Fujino, Takahiro
    Kuwahara, Saeko
    Ohshiro, Muneo
    Hirakawa, Yoshiko
    Iwai, Toshiki
    Uchiyama, Hitoji
    Kuroda, Junya
    Taniwaki, Masafumi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (03) : 443 - 444
  • [3] Erythroid but not cytogenetic response in a case with 5q-syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?
    Vigna, Ernesto
    Recchia, Anna Grazia
    Cuzzola, Maria
    Morabito, Lucio
    Gentile, Massimo
    Morabito, Fortunato
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1408 - 1409
  • [4] Long-Term Maintenance of Hematological and Cytogenetic Remission in 5q- Syndrome After Short-Term Administration of Lenalidomide
    Yuka Kawaji
    Hiroto Kaneko
    Takahiro Fujino
    Saeko Kuwahara
    Muneo Ohshiro
    Yoshiko Hirakawa
    Toshiki Iwai
    Hitoji Uchiyama
    Junya Kuroda
    Masafumi Taniwaki
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 443 - 444
  • [5] High Resolution Molecular Analysis of 5q-Syndrome Patients at Diagnosis and Following Lenalidomide Therapy
    Mohamedali, Azim M.
    Lea, Nicholas
    Twine, Natalie
    Gaken, Joop
    Chelliah, Rajani
    Westwood, Nigel
    Mufti, Ghulam J.
    BLOOD, 2008, 112 (11) : 90 - 90
  • [6] Dramatic response in the dependency to transfusion after low doses of lenalidomide treatment in a 5q-syndrome patient: a case report
    Dogu, Mehmet Hilmi
    Sari, Ismail
    Hacioglu, Sibel
    Keskin, Ali
    NORTHERN CLINICS OF ISTANBUL, 2014, 1 (03) : 191 - 193
  • [7] Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy
    Kourelis, Taxiarchis V.
    Kumar, Shaji K.
    Srivastava, Geetika
    Gertz, Morie A.
    Lacy, Martha Q.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Zeldenrust, Steven R.
    Leung, Nelson
    Kyle, Robert A.
    Russell, Stephen J.
    Dingli, David
    Lust, John A.
    Lin, Yi
    Kapoor, Prashant
    Go, Ronald
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) : 302 - 305
  • [8] Long-term complete remission in a multiple myeloma patient after Stevens-Johnson syndrome due to lenalidomide therapy
    Musolino, Caterina
    Alonci, Andrea
    Catena, Sara
    Rizzotti, Patricia
    Russo, Sabina
    Rotondo, Francesco
    Allegra, Alessandro
    ACTA ONCOLOGICA, 2013, 52 (05) : 1052 - 1054
  • [9] Long-Term Response in a Patient with del (5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge
    Pisani, Francesco
    Orlandi, Giulia
    Merola, Roberta
    CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 277 - 284
  • [10] LENALIDOMIDE AND 5Q MYELODISPLASTIC SYNDROME: HEMATOLOGICAL RESPONSE AFTER IMMUNOMODULATORY SUSPENSION AND CLONAL EVOLUTION. REVIEW OF THREE CASES
    Munoz Garcia, C.
    Dominguez Velasco, N.
    Manzanares Perez, M.
    Herruzo Delgado, B.
    Rodriguez Fernandez, A.
    HAEMATOLOGICA, 2018, 103 : 349 - 350
12345